To save content items to your account,
please confirm that you agree to abide by our usage policies.
If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account.
Find out more about saving content to .
To save content items to your Kindle, first ensure no-reply@cambridge.org
is added to your Approved Personal Document E-mail List under your Personal Document Settings
on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part
of your Kindle email address below.
Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations.
‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi.
‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
Localized surface plasmon resonance (LSPR) excitation in silver and gold nanoparticles produces strong extinction and scattering spectra that in recent years have been used for important sensing and spectroscopy applications. This article describes the fabrication, characterization, and computational electrodynamics of plasmonic materials that take advantage of this concept.Two applications of these plasmonic materials are presented: (1) the development of an ultrasensitive nanoscale optical biosensor based on LSPR wavelength-shift spectroscopy and (2) the use of plasmon-sampled and wavelength-scanned surface-enhanced Raman excitation spectroscopy (SERES) to provide new insight into the electromagnetic-field enhancement mechanism.
By
John F. Oates, Department of Anthropology, Hunter College, CUNY Graduate Center, 356 Fifth Avenue, New York, NY 10016, U.S.A.,
Kelley L. McFarland, PhD Program in Anthropology, CUNY Graduate Center, 365 Fifth Avenue, New York, NY 10016, U.S.A.,
Jaqueline L. Groves, Department of Biological Sciences, University of Sussex, Falmer BN1 9RH, U.K.,
Richard A. Bergl, PhD Program in Anthropology, CUNY Graduate Center, 356 Fifth Avenue, New York, NY 10016, U.S.A.,
Joshua M. Linder, PhD Program in Anthropology, CUNY Graduate Center, 365 Fifth Avenue, New York, NY 10016, U.S.A.,
Todd R. Disotell, Department of Anthropology, New York University, 25 Waverly Place, New York, NY 10003, U.S.A.
In this chapter we summarize information on the morphology, genetics, and natural history of the West African gorilla population inhabiting the forests on the Nigeria–Cameroon border at the northern headwaters of the Cross River, a region at the western and northern limits of the species' range. A recent morphological analysis of skeletal specimens from this population has shown that they are sufficiently distinct from other western gorillas to justify being classified as the subspecies Gorilla gorilla diehli, a taxonomic name originally applied to them in the early twentieth century (Sarmiento and Oates, 2000). Just as the distinctiveness of the Cross River gorillas is being appreciated, their continued survival is in jeopardy. Recent surveys suggest that approximately 250 probably remain, concentrated in nine or more isolated hill areas. Because these gorillas are still hunted for their meat and parts of their habitat are under threat, they are one of Africa's most endangered primate taxa. After reviewing data on the status of the Cross River gorillas, our chapter ends by discussing some options for improving their prospects for survival.
In addition to the literature, the information we summarize derives from our own research: Field surveys in Nigeria (by JFO and KLM) and Cameroon (by JLG); an ecological study of a subpopulation inhabiting Afi Mountain Wildlife Sanctuary, Nigeria (by KLM); and the sequencing of mtDNA extracted from hairs of Nigerian gorillas shed into sleeping nests (by RAB and JML in the laboratory of TRD). All our results should be regarded as preliminary.
To describe the epidemiology, diagnosis, risk factors, patient impact, and treatment strategies for recurrent Clostridium difficile-associated disease (CDAD).
Design:
Data were collected as part of a blinded, placebo-controlled clinical trial testing a new combination treatment for recurrent CDAD. Retrospective data regarding prior CDAD episodes were collected from interviews and medical-chart review. Prospective data on the current CDAD episode, risk factors, and recurrence rates were collected during a 2-month follow-up.
Settings:
National referral study.
Participants:
Patients with recurrent CDAD.
Interventions:
Treatment with a 10-day course of low-dose (500 mg/d) or high-dose (2 g/d) vancomycin or metronidazole (1 g/d).
Results:
Recurrent CDAD was found to have a lengthy course involving multiple episodes of diarrhea, abdominal cramping, nausea, and fever. CDAD may recur over several years despite frequent treatment with antibiotics. Recurrence rates were similar regardless of the choice or dose of antibiotic. Recurrent CDAD is not a trivial disease: patients may have multiple episodes (as many as 14), may require hospitalization, and the mean lifetime cost of direct medical care was $10,970 per patient. Fortunately, the disease does not become progressively more severe as the number of episodes increase. Two risk factors predictive for recurrent CDAD were found: increasing age and a decreased quality-of-life score at enrollment.
Conclusions:
Recurrent CDAD is a persistent disease that may result in prolonged hospital stays, additional medical costs, and rare serious complications.
Recommend this
Email your librarian or administrator to recommend adding this to your organisation's collection.